3 March 2015Comments ( 5 )
Understanding why some children appear to outgrow their autism diagnosis may provide clues about the biology of the disorder but shouldn’t dictate treatment decisions, says Deborah Fein.
17 February 2015Comments ( 3 )
Drugs designed to treat fragile X syndrome have yet to show substantial benefits in people. But rather than abandon them, child neurologist Elizabeth Berry-Kravis suggests a new way to measure their effectiveness.
20 January 2015Comments ( 5 )
Existing autism therapies do little to lower the lifetime costs of having the disorder, so clinicians should consider more efficient and inexpensive alternatives, says David Mandell.
2 January 2015Comments ( 7 )
Names such as autism, schizophrenia and intellectual disability are ‘umbrella’ terms that muddy the search for the true cause of an individual’s symptoms, says Eric London. He plans to come up with an alternative diagnostic scheme for developmental disabilities over the next two years.
24 November 2014Comments ( 0 )
Finding people who have an autism-linked mutation but no apparent symptoms may be the key to identifying drug targets for the disorder, says Thomas Insel, director of the National Institute of Mental Health.